Securing Critical Drug Supply: Establishing Rolling Pharmaceutical Ingredient Reserves.
This Act establishes a national strategic reserve program aimed at preventing shortages of critical drugs and their active ingredients. The government will contract with pharmaceutical companies to maintain a minimum six-month supply of these essential medicines, which must be regularly replenished. This ensures citizens have continuous access to necessary medications, especially during public health crises and security threats.
Key points
Mandatory creation of rolling reserves (6-month supply) of critical drugs and their active ingredients to prevent supply chain disruptions.
Preference given to domestic manufacturers to strengthen US production capacity and resilience during emergencies.
Allows the government to direct the allocation of active ingredient reserves during severe shortages or public health emergencies.
Expired
Citizen Poll